Managing Type 1 diabetes through the teenage years is substantially harder than managing it through childhood, and most families know this before it happens – but the reality is often more demanding than anticipated. The difficulty is not just biological, though the biology is genuinely more unpredictable during puberty. It is also developmental: this is the age when the responsibility for a complex medical condition needs to transfer from parents to the young person themselves, which happens at exactly the age when teenagers are, by design, pushing against parental control.
Understanding the biology of why control worsens in adolescence, and the developmental principles of what a healthy handover of responsibility looks like, helps families navigate the teenage years without the management of diabetes becoming a daily battleground.
Healthbooq (healthbooq.com/apps/healthbooq-kids) covers chronic conditions in children and adolescents.
Why Adolescence Is Harder for Blood Glucose Management
Puberty involves significant hormonal changes that directly affect insulin sensitivity. Growth hormone levels increase dramatically during the adolescent growth spurt, and growth hormone is a counter-regulatory hormone: it raises blood glucose and reduces the effectiveness of insulin. Cortisol, sex hormones, and the changes in body composition associated with puberty (increase in fat mass in girls, increase in muscle mass in boys) all affect insulin requirements in ways that are variable and often unpredictable.
The result is what diabetes teams often call the "adolescent insulin resistance" phenomenon: the same insulin dose that produced stable glucose levels at age 10 may no longer be adequate at 13, without any change in diet or activity. Insulin requirements typically increase significantly through puberty, sometimes by 30-50% or more. The unpredictability of this increase – combined with the unpredictability of adolescent eating patterns, exercise, sleep, alcohol, and stress – is what makes HbA1c typically worsen during the teenage years even in engaged families.
Research by Georgeanna Klingensmith and colleagues at the Barbara Davis Center for Diabetes at the University of Colorado, and UK-based data from the Royal College of Paediatrics and Child Health's (RCPCH) National Paediatric Diabetes Audit, consistently document this pattern: mean HbA1c rises from childhood into adolescence and then partially improves in early adulthood. This is not evidence of failure; it is the expected physiological and psychosocial pattern.
Technology and Its Impact
The past decade has transformed the technical options available to young people with Type 1 diabetes.
Continuous glucose monitoring (CGM) – devices that measure interstitial glucose every few minutes and display the trend on a phone or reader – have significantly improved both safety (by detecting hypoglycaemia before it becomes dangerous) and quality of life (by reducing the number of finger-prick tests and providing much better insight into glucose patterns). Libre (Abbott) and Dexcom CGMs are the most widely used in the UK; both are available on the NHS for people with Type 1 diabetes.
Closed-loop or "hybrid closed-loop" systems – often called artificial pancreas systems – combine a CGM with an insulin pump and an algorithm that adjusts insulin delivery automatically in response to glucose levels. In the UK, the CamAPS FX system (developed by Roman Hovorka's group at the University of Cambridge) has been approved and is available through NHS diabetes services. Multiple trials have documented that hybrid closed-loop systems substantially improve time-in-range (the proportion of time the glucose is within target) and significantly reduce both hypoglycaemia and hypoglycaemia-related anxiety for the young person and their family. For teenagers in particular, who may be less reliable at manual dosing, closed-loop systems offer a significant safety benefit.
Not all NHS diabetes services have moved to closed-loop uniformly, and access varies. Families who believe a closed-loop system would benefit their child can discuss this directly with the diabetes team.
The Transition of Responsibility
The question of how and when to transfer management from parent to teenager is one of the central challenges of paediatric diabetes care. Both extremes are problematic: a 15-year-old whose parents still manage all their diabetes decisions is not developing the self-management skills they will need in adulthood. A 13-year-old who has been expected to manage independently before they are developmentally ready may disengage, feel overwhelmed, or hide poor control.
Research by Barbara Anderson at Baylor College of Medicine has documented what might be called the "shared management" approach: a gradual, intentional transfer of responsibility that begins in early adolescence, with the parent remaining involved and informed while the young person progressively takes more control. This is associated with better glycaemic outcomes than either full parental control or premature full independence.
Practical elements of this include: who sets the pump basal rates (shared decision until the teenager understands the rationale and can adjust independently), who manages CGM alerts at night (often the parent), who calculates bolus doses (initially taught and checked, then gradually independent), and how much detail the parent sees on the CGM share function (maintaining visibility without hourly messages demanding explanation of every glucose excursion).
Psychologist Korey Hood at the University of Washington has contributed substantially to understanding the psychological aspects of adolescent diabetes management, particularly the role of family conflict around diabetes – criticism, nagging, and conflict about readings – in predicting worse glycaemic outcomes. Conflict about diabetes is, counterintuitively, associated with parents withdrawing from involvement rather than more engagement – the teenager's response to constant diabetes-focused pressure is to disengage from management entirely.
HbA1c and What It Means
HbA1c is a measure of average blood glucose over the preceding 8-12 weeks. The NHS target for teenagers with Type 1 diabetes is below 48 mmol/mol (6.5%), though the NICE target recognises that this is aspirational and that individual circumstances affect what is achievable. The RCPCH National Paediatric Diabetes Audit data consistently shows that a significant proportion of teenagers have HbA1c above 80 mmol/mol (9.5%), which is associated with significantly increased risk of complications.
It is important that HbA1c not be used primarily as a source of shame and failure: a teenager who is already struggling with diabetes management and who is then presented with a high HbA1c as evidence of their inadequacy is less likely to re-engage, not more. Diabetes teams that use HbA1c as a starting point for understanding what is making management difficult – rather than a metric of adherence – tend to have better outcomes.
Diabetic Ketoacidosis (DKA) Risk
DKA – the dangerous metabolic acidosis that results from profound insulin deficiency – remains a significant risk in adolescence, because adolescents are more likely to miss insulin doses, use alcohol (which masks hypoglycaemia symptoms), and encounter situations where insulin management is disrupted. The BSPED (British Society for Paediatric Endocrinology and Diabetes) DKA guidelines provide the management framework for acute presentations.
Teenagers with Type 1 diabetes should understand the signs of developing DKA (high glucose not responding to correction doses, ketones present on testing, nausea, abdominal pain) and know to seek medical attention before DKA becomes severe. The "sick day rules" – how to manage insulin and ketone monitoring when unwell – should be part of the education of every young person with Type 1 diabetes.
Living as a Teenager with Diabetes
The social and psychological burden of Type 1 diabetes in adolescence is significant and is often underestimated by professionals. The constant management demands, the visibility of insulin pumps and CGMs, the need to explain the condition to friends, the inability to simply eat like everyone else, and the knowledge of long-term complication risk all contribute to higher rates of anxiety and depression in young people with Type 1 diabetes compared with their peers.
Peer support – through Diabetes UK's advocacy and community programmes, through T1D-specific social media communities, and through the increasing visibility of public figures with Type 1 diabetes – is genuinely protective for adolescents who feel isolated in managing the condition.
Diabetes UK provides comprehensive resources for young people and their families, including advice on managing diabetes at school, during exams, and during transition to adult services.
Key Takeaways
The adolescent years are the most challenging period in the course of Type 1 diabetes management. Hormonal changes during puberty – particularly growth hormone and cortisol surges – increase insulin resistance and unpredictability in glucose levels. At the same time, the transition from parent-managed to self-managed care requires gradual transfer of responsibility that, if handled badly in either direction, leads to either excessive parental control or adolescent disengagement. HbA1c typically worsens during adolescence even in well-supported families. Continuous glucose monitoring (CGM) technology has significantly improved the safety and quality of life of young people with Type 1 diabetes, and closed-loop insulin delivery is increasingly available.
